2-chloroadenosine has been researched along with Recrudescence in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, J; Lin, H; Penumalli, V; Rezania, K; Soliven, B; van Besien, K | 1 |
| Ferrari, J; Lang, W; Müllauer, L; Raderer, M; Thurnher, S | 1 |
| Januszewicz, H; Quach, H; Westerman, D | 1 |
| Juliusson, G; Liliemark, J | 1 |
| Blakley, RL; Crom, W; Kearns, C; Mirro, J; Santana, VM; Schell, MJ | 1 |
1 review(s) available for 2-chloroadenosine and Recrudescence
| Article | Year |
|---|---|
Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature.
Topics: 2-Chloroadenosine; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Deoxyadenosines; Fatal Outcome; Female; Humans; Lymphoma; Lymphoma, Follicular; Lymphoproliferative Disorders; Male; Middle Aged; Myasthenia Gravis; Paraneoplastic Syndromes, Nervous System; Prednisone; Pyridostigmine Bromide; Recurrence; Remission Induction; Rituximab; Waldenstrom Macroglobulinemia | 2012 |
1 trial(s) available for 2-chloroadenosine and Recrudescence
| Article | Year |
|---|---|
2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia.
Topics: 2-Chloroadenosine; Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cladribine; Combined Modality Therapy; Deoxyadenosines; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Regression Analysis; Remission Induction | 1992 |
3 other study(ies) available for 2-chloroadenosine and Recrudescence
| Article | Year |
|---|---|
Bilateral facial nerve palsy as first indication of relapsing hairy cell leukemia after 36 years.
Topics: 2-Chloroadenosine; Aged; Antimetabolites, Antineoplastic; Arm; Deoxyadenosines; Diagnosis, Differential; Diplopia; Facial Paralysis; Female; Humans; Hypesthesia; Leukemia, Hairy Cell; Lymph Nodes; Recurrence; Remission Induction; Stroke; Survivors | 2004 |
Complete remission of hairy cell leukemia variant (HCL-v) complicated by red cell aplasia post treatment with rituximab.
Topics: 2-Chloroadenosine; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Combined Modality Therapy; Cyclophosphamide; Deoxyadenosines; Disease Progression; Drug Resistance, Neoplasm; Fatal Outcome; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Neoplasms, Second Primary; Prednisolone; Recurrence; Red-Cell Aplasia, Pure; Remission Induction; Rituximab; Splenectomy; Urinary Bladder Neoplasms | 2005 |
Retreatment of chronic lymphocytic leukemia with 2-chlorodeoxyadenosine (CdA) at relapse following CdA-induced remission: no acquired resistance.
Topics: 2-Chloroadenosine; Aged; Chlorambucil; Drug Resistance; Erythrocyte Transfusion; Female; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Middle Aged; Platelet Transfusion; Recurrence; Remission Induction; Time Factors; Vidarabine | 1994 |